IMLYGIC (talimogene laherparepvec)
STN: 125518
Proper Name: talimogene laherparepvec
Tradename: IMLYGIC
Manufacturer: Amgen Inc.
Indication:
-
Indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.